Intellia Therapeutics (NTLA) EBT Margin Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 48,476.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 441.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -408.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 7,297.00 |
| 10 | Intellia Therapeutics | 1.63 Bn | 1.63 Bn | - | 15,961.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15,961.00 |
| Dec 31, 2025 | 37,091.00 |
| Sep 30, 2025 | 2,069.00 |
| Jun 30, 2025 | -2,457.00 |
| Mar 31, 2025 | 60,233.00 |
| Dec 31, 2024 | -35,560.00 |
| Sep 30, 2024 | 2.24 Mn |
| Jun 30, 2024 | -76,958.00 |
| Mar 31, 2024 | 36,657.00 |
| Dec 31, 2023 | 728,728.00 |
| Sep 30, 2023 | -86,176.00 |
| Jun 30, 2023 | -68,121.00 |
| Mar 31, 2023 | -15,698.00 |
| Dec 31, 2022 | -51,307.00 |
| Sep 30, 2022 | -55,820.00 |
| Jun 30, 2022 | -46,463.00 |
| Mar 31, 2022 | -106,687.00 |
| Dec 31, 2021 | -37,974.00 |
| Sep 30, 2021 | -2.36 Mn |
| Jun 30, 2021 | -76,105.00 |
| Mar 31, 2021 | -43,098.00 |
| Dec 31, 2020 | -28,038.00 |
| Sep 30, 2020 | 8,457.00 |
| Jun 30, 2020 | 6,435.00 |
| Mar 31, 2020 | -43,289.00 |
| Dec 31, 2019 | -7,084.00 |
| Sep 30, 2019 | -6,896.00 |
| Jun 30, 2019 | -6,695.00 |
| Mar 31, 2019 | 16,613.00 |
| Dec 31, 2018 | 8,238.00 |
| Sep 30, 2018 | -11,090.00 |
| Jun 30, 2018 | -4,091.00 |
| Mar 31, 2018 | -19,300.00 |